Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New MRI trick sharpens ovarian lesion diagnosis

NCT ID NCT07202429

Diagnosis Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether adding a special MRI measurement (called ADC) to the standard scoring system helps doctors more accurately tell if ovarian growths are cancerous. Researchers reviewed MRI scans from 66 women with suspicious ovarian lesions found on ultrasound. The goal was to see if the combined approach improves diagnosis compared to the standard method alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

66 people

The number who actually took part.

Started

Mar 2023

Finished

Jan 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

female patients any age with ovarian lesions

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * (1) Female patient any age with at least one adnexal lesion detected by U/S reported as O-RADS3to5. (2) The interval between operation and ultrasonography did not exceed 120 days. (3) Subsequent surgery with histological examination or stability at follow-up imaging for at least 1 year. (4) For bilateral adnexal masses, the mass with the most complex features was included. (5)If two masses had similar morphologies, the largest mass was included. Exclusion Criteria: 1. Female patient any age with adnexal lesions detected by U/S reported as O-RADS1and2. 2. Cysts that were deemed to be clearly physiological and less than 3 cm in maximum diameter. 3. No histopathological findings or follow-up \< one year . 4. Previous bilateral adnexectomy. 5. Contraindications to MRI examination including * Absolute contraindications: such as The cardiac implantable electronic device (CIED), Metallic intraocular foreign bodies, ….) * Relative contraindications: such as Coronary and peripheral artery stents, Ocular prosthesis,……)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ovarian neoplasms are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

ovarian cancer ovarian neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Ovarian neoplasms

Contacts and locations

Locations

  • Kasr Al-Ainy Faculty of Medicine, Cairo University

    Cairo, Cairo Governorate, 11562, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.